Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapy
cell therapy
Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraise
BioPharma Dive
Wed, 03/20/24 - 11:35 am
Capstan Therapeutics
cell therapy
funding
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters
Fri, 03/15/24 - 10:57 am
Gilead Sciences
cell therapy
cancer
drug manufacturing
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Asgard Therapeutics
in vivo cell therapy
cell therapy
JNJ
Novo Nordisk
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
FDA
JNJ
Bristol Myers Squibb
blood cancers
cell therapy
BioCardia rejigs phase 3 heart failure data to find a path forward for cell therapy
Fierce Biotech
Mon, 03/4/24 - 11:43 pm
BioCardia
cell therapy
heart failure
CardiAMP
clinical trials
Iovance receives more good news as FDA lifts hold on lung cancer cell therapy trial
Fierce Biotech
Mon, 03/4/24 - 11:50 am
Iovance Biotherapeutics
FDA
LN-145
lung cancer
cell therapy
clinical trials
Cure Ventures backs a cell therapy startup targeting Parkinson’s
BioPharma Dive
Thu, 02/29/24 - 06:58 pm
Kenai Therapeutics
cell therapy
Parkinson's Disease
funding
Cure Ventures
FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
Sun, 02/18/24 - 08:39 pm
Iovance
FDA
Amtagvi
solid tumors
t-cell therapies
cell therapy
Neurona raises another $120M for brain disease cell therapies
BioPharma Dive
Thu, 02/8/24 - 09:55 pm
Neurona
funding
epilepsy
cell therapy
BioNTech partners with Autolus to boost cell therapy manufacturing
BioPharma Dive
Thu, 02/8/24 - 11:16 am
BioNTech
Autolus
cell therapy
drug manufacturing
AstraZeneca to invest $300 million in US facility for cell therapies
Reuters
Tue, 02/6/24 - 11:38 pm
AstraZeneca
cell therapy
Kyverna sets IPO range, eyeing $180M haul to fund broad autoimmune CAR-T clinical trial program
Fierce Biotech
Thu, 02/1/24 - 11:19 am
Kyverna Therapeutics
IPOs
cell therapy
autoimmune disease
2seventy bio to sell experimental cell therapies, names new CEO
Reuters
Tue, 01/30/24 - 10:23 am
2seventy bio
Regeneron
Abecma
cell therapy
CAR-T hype faces infrastructure reality check
Fierce Pharma
Tue, 01/16/24 - 09:22 am
CAR-T
cell therapy
gene therapy
Gilead Sciences
JNJ
JPM24, Day 3: Gene editors take the stage to talk business development, germline edits
Fierce Biotech
Wed, 01/10/24 - 11:56 am
JPMHC 2024
gene editing
cell therapy
Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies
BioSpace
Tue, 01/9/24 - 10:52 am
Factor Bioscience
Department of Defense
cell therapy
MRNA
Gene Therapy Approvals Expected to Ramp Up in 2024 Amid Manufacturing, Cost Challenges
BioSpace
Tue, 01/9/24 - 10:24 am
gene therapy
cell therapy
FDA
Allogene to shift strategy in bid to reposition CAR-T
BioPharma Dive
Fri, 01/5/24 - 10:03 am
Allogene Therapeutics
cell therapy
cancer
CAR-T
AbbVie is big pharma’s first mover in ‘in situ’ cell therapy
Pharmaphorum
Fri, 01/5/24 - 09:48 am
AbbVie
Umoja Biopharma
cell therapy
in situ cell therapy
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
AstraZeneca
Gracell
cell therapy
M&A
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »